Enveric Biosciences, Inc. (ENVB) stock
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52+0.03 (+2.01%)
Close on Nov 12, 2026Market cap $6.80MP/E –Yield –
Enveric Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Enveric Biosciences's enterprise value was -$2.43M on Nov 11, 2026, against -$782.58K a year earlier. Over the last 5 years it ranged from -$2.90M to $78.78B, with a median of $8.71B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.43M | – |
| 2025 | Dec 31, 2025 | -$1.88M | -100.0% |
| 2024 | Dec 31, 2024 | $8.70B | +13.7% |
| 2023 | Dec 29, 2023 | $7.65B | -34.3% |
| 2022 | Dec 30, 2022 | $11.65B | -85.2% |
| 2021 | Dec 31, 2021 | $78.78B | +243.7% |
| 2020 | Dec 31, 2020 | $22.92B | -62.6% |
| 2019 | Dec 31, 2019 | $61.33B | +42.2% |
| 2018 | Dec 31, 2018 | $43.12B | -91.9% |
| 2017 | Dec 29, 2017 | $530.87B | -44.0% |
| 2016 | Dec 30, 2016 | $948.10B | +14.3% |
| 2015 | Dec 31, 2015 | $829.61B | – |
See a number that looks wrong?